Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.
Fiorina P, Vergani A, Dada S, Jurewicz M, Wong M, Law K, Wu E, Tian Z, Abdi R, Guleria I, Rodig S, Dunussi-Joannopoulos K, Bluestone J, Sayegh MH.
Diabetes. 2008 Nov;57(11):3013-24. Epub 2008 Aug 8.PMID: 18689692 [PubMed - indexed for MEDLINE]Related articlesFree article